The CXCL9-CXCR3 axis involves recruiting immune cells into the tumour microenvironment in a variety of solid tumours, such as epithelial ovarian cancer, non-small-cell lung cancer, melanoma, breast cancer, and colon cancer [29–35]. Here, CXCL9 is linked to neoplasm.